[1]
“An Open Label Clinical Study Evaluating the Effectiveness of a Cryptolepis sanguinolenta based Herbal Antimalarial Agent”, AJBR, bd. 22, nr. 3, s. 257–262, dec. 2019, Set: 4. april 2026. [Online]. Tilgængelig hos: https://ojshostng.com/index.php/ajbr/article/view/1321